Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Maplebear (CART) Q2 Earnings and Revenues Beat Estimates
Maplebear (CART) Q2 Earnings and Revenues Beat Estimates

Maplebear (CART) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.2 per share a year ago. These figures

GigaCloud Technology Inc. (GCT) Q2 Earnings and Revenues Surpass Estimates
GigaCloud Technology Inc. (GCT) Q2 Earnings and Revenues Surpass Estimates

GigaCloud Technology Inc. (GCT) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.65 per share a year ago

GoDaddy (GDDY) Q2 Earnings and Revenues Top Estimates
GoDaddy (GDDY) Q2 Earnings and Revenues Top Estimates

GoDaddy (GDDY) came out with quarterly earnings of $1.41 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.1 per share a year ago. These figures are

Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Lags Revenue Estimates
Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Lags Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to a loss of $0.51 per share a year ago

Akamai Technologies (AKAM) Surpasses Q2 Earnings and Revenue Estimates
Akamai Technologies (AKAM) Surpasses Q2 Earnings and Revenue Estimates

Akamai Technologies (AKAM) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.58 per share a year ago

BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2

BioLife Solutions, Inc. (BLFS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.06 per share a year ago. These

Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates

Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.08 per share a year ago. These figures

Expedia (EXPE) Beats Q2 Earnings and Revenue Estimates
Expedia (EXPE) Beats Q2 Earnings and Revenue Estimates

Expedia (EXPE) came out with quarterly earnings of $4.24 per share, beating the Zacks Consensus Estimate of $4.14 per share. This compares to earnings of $3.51 per share a year ago. These figures

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat EstimatesPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates

Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.94 per share a year

Texas Roadhouse (TXRH) Lags Q2 Earnings Estimates
Texas Roadhouse (TXRH) Lags Q2 Earnings Estimates

Texas Roadhouse (TXRH) came out with quarterly earnings of $1.86 per share, missing the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $1.79 per share a year ago. These

Clipper Realty Inc. (CLPR) Beats Q2 FFO Estimates
Clipper Realty Inc. (CLPR) Beats Q2 FFO Estimates

Clipper Realty Inc. (CLPR) came out with quarterly funds from operations (FFO) of $0.2 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to FFO of $0.17 per share a

Ascend Wellness Holdings, Inc. (AAWH) Reports Q2 Loss, Misses Revenue Estimates
Ascend Wellness Holdings, Inc. (AAWH) Reports Q2 Loss, Misses Revenue Estimates

Ascend Wellness Holdings, Inc. (AAWH) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.1 per share a year ago

The Trade Desk (TTD) Lags Q2 Earnings Estimates
The Trade Desk (TTD) Lags Q2 Earnings Estimates

The Trade Desk (TTD) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.39 per share a year ago. These

Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue Estimates
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue Estimates

Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.34 per share a year ago. These

Cytokinetics (CYTK) Reports Q2 Loss, Tops Revenue Estimates
Cytokinetics (CYTK) Reports Q2 Loss, Tops Revenue Estimates

Cytokinetics (CYTK) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus Estimate of a loss of $1.34. This compares to a loss of $1.31 per share a year ago. These figures are

Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates
Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates

Arcellx, Inc. (ACLX) came out with a quarterly loss of $0.94 per share versus the Zacks Consensus Estimate of a loss of $1.03. This compares to a loss of $0.51 per share a year ago. These figures

Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates
Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates

Dynavax Technologies (DVAX) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.08 per share a year ago

Top Research Reports for NVIDIA, Palantir & Coca-ColaPhoto, wide shot, wide-angle lens,  Cloud computing provider, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/8d7b6619-8b3b-4e9e-b659-68643d72528e.png
Top Research Reports for NVIDIA, Palantir & Coca-Cola

Thursday, August 7, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA

Buy the Spike in AppLovin Stock after Q2 earnings?
Buy the Spike in AppLovin Stock after Q2 earnings?

AppLovin APP continued its growing popularity as one of the market’s top momentum stocks after exceeding its Q2 expectations on Wednesday evening.

The marketing and technology provider for apps has

Appian (APPN) Reports Q2 Earnings: What Key Metrics Have to Say
Appian (APPN) Reports Q2 Earnings: What Key Metrics Have to Say

Appian (APPN) reported $170.64 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 16.5%. EPS of $0 for the same period compares to -$0.26 a year ago.

The

Compared to Estimates, Targa Resources (TRGP) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Targa Resources (TRGP) Q2 Earnings: A Look at Key Metrics

Targa Resources, Inc. (TRGP) reported $4.26 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 19.6%. EPS of $2.87 for the same period compares to $1.33 a

Sabre (SABR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Sabre (SABR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, Sabre (SABR) reported revenue of $687.15 million, down 10.4% over the same period last year. EPS came in at -$0.02, compared to -$0.05 in the year-ago quarter.

The

Palantir Achieves $1B Revenues, Is It Too Late to Invest?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/ec495607-1e17-40ee-a41d-7726313a9707.png
Palantir Achieves $1B Revenues, Is It Too Late to Invest?

Due to the rapid growth of artificial intelligence (AI), large tech companies like NVIDIA Corporation NVDA and Amazon.com, Inc. AMZN have experienced substantial expansion, raising questions about

Is CVS a Smart Buy Now on Strong Q2, Low Valuation & Long-Term Upside?
Is CVS a Smart Buy Now on Strong Q2, Low Valuation & Long-Term Upside?

Investors responded with optimism following CVS Health’s CVS second-quarter 2025 earnings release last week, buoyed by better-than-expected earnings and revenue growth, improved segment performance

Epam (EPAM) Beats Q2 Earnings Estimates (Revised)
Epam (EPAM) Beats Q2 Earnings Estimates (Revised)

Epam (EPAM) came out with quarterly earnings of $2.77 per share, missing the Zacks Consensus Estimate of $2.61 per share. This compares to earnings of $2.45 per share a year ago. These figures are